ReviewFrontiers in immunology2017
Indoleamine 2,3-Dioxygenase and Tolerance: Where Are We Now?
Andrew L Mellor et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
132 papers cite itlatest 60 shown
this papertrialcites it
ReviewFrontiers in immunology2017
Andrew L Mellor et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.